Irritable Bowel Syndrome—The Main

[1]  W. Chey,et al.  Rifaximin therapy for patients with irritable bowel syndrome without constipation. , 2011, The New England journal of medicine.

[2]  AWMF-Registriernummer.  S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)1 , 2011 .

[3]  M. Currie,et al.  Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. , 2010, Gastroenterology.

[4]  D. Drossman,et al.  Functional Bowel Disorders , 1995, The American Journal of Gastroenterology.

[5]  T. Peters,et al.  Risk of ovarian cancer in women with symptoms in primary care: population based case-control study , 2009, BMJ : British Medical Journal.

[6]  P. Moayyedi,et al.  Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis , 2009, The American Journal of Gastroenterology.

[7]  K. Garsed,et al.  Postinfectious irritable bowel syndrome. , 2009, Gastroenterology.

[8]  P. Moayyedi,et al.  Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. , 2009, Archives of internal medicine.

[9]  Rafael Perera,et al.  A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome , 2009, BMC gastroenterology.

[10]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[11]  P. Moayyedi,et al.  Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis , 2008, BMJ : British Medical Journal.

[12]  P. Moayyedi,et al.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.

[13]  M. Camilleri,et al.  A placebo-controlled trial of prucalopride for severe chronic constipation. , 2008, The New England journal of medicine.

[14]  S. Dublin,et al.  Meta-analysis of probiotics for the treatment of irritable bowel syndrome. , 2008, World journal of gastroenterology.

[15]  M. Camilleri,et al.  Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  A. Salas,et al.  Systematic Evaluation of the Causes of Chronic Watery Diarrhea With Functional Characteristics , 2007, The American Journal of Gastroenterology.

[17]  N. Urban,et al.  Development of an ovarian cancer symptom index: possibilities for earlier detection. , 2007, Cancer.

[18]  N. Urban,et al.  Development of an ovarian cancer symptom index , 2007 .

[19]  V. Khoshoo,et al.  Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome , 2006, Alimentary pharmacology & therapeutics.

[20]  L. Smith,et al.  Early symptoms of ovarian cancer: a case-control study without recall bias. , 2005, Family practice.

[21]  N. D. de Wit,et al.  Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. , 2005, The Cochrane database of systematic reviews.

[22]  B. Goff,et al.  Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. , 2004, JAMA.

[23]  B. Oldenburg,et al.  IBS-Like Symptoms in Patients with Inflammatory Bowel Disease in Remission; Relationships with Quality of Life and Coping Behavior , 2004, Digestive Diseases and Sciences.

[24]  A. Berchuck,et al.  Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. , 2003, Gynecologic oncology.

[25]  F. Shanahan,et al.  Celiac disease and irritable bowel-type symptoms. , 2002 .

[26]  D. Sanders,et al.  Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care , 2001, The Lancet.

[27]  M. Wallander,et al.  Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. , 2000, Scandinavian journal of gastroenterology.

[28]  広瀬 順子.  「過敏性腸症候群(IBS)の長期予後と治療者-患者関係」Owens DM, Nelson DK, Talley NJ : The irritable bowel syndrome : Long-term prognosis and the physician-patient interaction. Ann Intern Med 122(2) : 107-112,1995 , 1996 .

[29]  M. Vatn,et al.  A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome. , 1996, Scandinavian journal of gastroenterology.

[30]  N. Talley,et al.  The Irritable Bowel Syndrome: Long-Term Prognosis and the Physician-Patient Interaction , 1995, Annals of Internal Medicine.

[31]  K. Ewe,et al.  [The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon]. , 1990, Fortschritte der Medizin.